Related Experiment Video
Updated: Feb 27, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Adipokines in Liver Cirrhosis
Christa Buechler1, Elisabeth M Haberl2, Lisa Rein-Fischboeck3
1Department of Internal Medicine I, University Hospital Regensburg, 93042 Regensburg, Germany. christa.buechler@klinik.uni-regensburg.de.
Adipokines, proteins from fat tissue, may influence liver fibrosis severity. Studies analyze adipokine levels in cirrhosis patients to understand their role in liver disease progression and complications.
Area of Science:
- Hepatology
- Endocrinology
- Biochemistry
Background:
- Liver fibrosis can advance to cirrhosis, a severe condition impacting liver function.
- Portal hypertension is a key complication of cirrhosis, leading to ascites and bleeding.
- Adipokines, released by adipose tissue, influence liver processes like inflammation and fibrosis.
Purpose of the Study:
- To review the role of adipokines in hepatitis and liver fibrosis.
- To identify adipokines with altered circulating levels in liver cirrhosis patients.
- To explore associations between adipokines and liver function, portal hypertension, and complications.
Main Methods:
- Literature review of studies analyzing adipokines in cirrhotic patients.
- Analysis of adipokine levels in systemic, hepatic, and portal vein blood.
- Examination of adipokine changes after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Main Results:
- Adiponectin shows protective effects against hepatic inflammation and fibrogenesis.
- Leptin acts as a profibrogenic factor in liver disease.
- Circulating adipokine levels vary among different cohorts of liver cirrhosis patients.
Conclusions:
- Adipokines are implicated in modulating the severity of liver cirrhosis.
- Further research is needed to fully elucidate the role of specific adipokines in liver disease.
- Understanding adipokine profiles may offer insights into disease progression and potential therapeutic targets.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Nephrotic Syndrome I : Introduction

